Can-Fite Biopharma Ltd (CANF) vs Kairos Pharma, Ltd. (KAPA)
Can-Fite Biopharma Ltd and Kairos Pharma, Ltd. are both Biotechnology companies. Can-Fite Biopharma Ltd and Kairos Pharma, Ltd. are of similar size ($6.5M and $6.1M). Kairos Pharma, Ltd. has the higher net margin (0.00% vs −1,148.6%) and the lower return on invested capital (−322.9% vs 0.00%). Across the 10 metrics below, Can-Fite Biopharma Ltd leads on 5 and Kairos Pharma, Ltd. on 5.
Valuation
Profitability
| Metric | CANF | KAPA | Biotechnology median |
|---|---|---|---|
| Gross margin | 0.00% | — | 65.16% |
| Operating margin | 0.00% | 0.00% | 0.00% |
| Net margin | (1,148.62%) | 0.00% | 0.00% |
| Free cash flow margin | 0.00% | 0.00% | 0.00% |
| Return on equity | 0.00% | (113.96%) | (57.72%) |
| Return on assets | 0.00% | (104.32%) | (49.22%) |
| Return on invested capital | 0.00% | (322.91%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack